| ASSEMBLY BIOSCIENCES INC |
| USA |
| Gesundheit |
| US0453962070 / A402CB |
| V7B (Frankfurt) / ASMB (NASDAQ) |
| FRA:V7B, ETR:V7B, V7B:GR, NASDAQ:ASMB |
| - |
| https://www.assemblybio.c.. |
|
Assembly Biosciences Inc. is a clinical-stage biotechnology company focused on developing small-molecule therapeutics for serious viral and liver diseases. Its current pipeline includes investigational treatments for recurrent genital herpes, hepatit..
>Volltext.. |
| 391.87 Mio. EUR |
| 111.71 Mio. EUR |
| 67.47 Mio. EUR |
| -7.83 Mio. EUR |
| -0.04 Mio. EUR |
| -0.07 EUR |
| 2.12 Mio. EUR |
| 29.11 Mio. EUR |
| -34.69 Mio. EUR |
| 13.66 |
| 132.2% |
| 99.89% |
| - |
| - |
| - |
| ASSEMBLY BIOSCIENCES, ASSEMBLY BIO, ASSEMBLY BIOSCIENCE |
| 13.11.26 |
|